38.15GBp+2.55%Mkt Cap: 30.06M $P/E: —1d ago
Novacyt S.A., together with its subsidiaries, develops, manufactures, and commercializes a range of molecular assays and instrumentation to deliver workflows and services for human health, animal health, and environmenta…
Industry Peers
Medical DevicesIndicators:|
Key Statistics
Company
Market Cap30.06M $
Enterprise Value19.71M $
Revenue (TTM)21.77M $
Gross Profit13.71M $
Net Income (TTM)-24.87M $
Revenue/Share0.3087 USD
Last Price38.15 GBp
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees216
CountryGB
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-5.48
PEG—
EV/EBITDA6.99
EV/Revenue0.91
P/S1.38
P/B1.15
EPS (TTM)-0.33
EPS (Forward)-0.07
52W Range
26.6019% of range86.00
52W High86.00 GBp
52W Low26.60 GBp
Profitability
Gross Margin62.98%
Oper. Margin-59.36%
EBITDA Margin12.95%
Profit Margin-114.25%
ROE-97.91%
ROA-56.74%
Growth
Revenue Growth6.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-9.79M $
CapEx (TTM)957.61K $
FCF Margin36.82%
FCF Yield26.66%
Net Debt-9.58M $
Net Debt/EBITDA-3.40
Balance Sheet
Debt/Equity0.45
Current Ratio4.75
Quick Ratio4.16
Book Value/Sh0.3310 GBp
Cash/Share0.2730 GBp
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 GBp
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)66.00 GBp
Upside (mean)+73.0%
Target Range66.00 GBp – 66.00 GBp
# Analysts1
Ownership
Shares Out.72.50M
Float70.41M
Insiders0.06%
Institutions0.00%
Technical
SMA 5041.62 (-8.3%)
SMA 20037.16 (+2.7%)
Beta1.11
S&P 52W Chg20.25%
Avg Vol (30d)112.45K
Avg Vol (10d)49.73K
Technical Indicators
RSI (14)55.3
MACD-0.6262
MACD Signal-1.2839
MACD Hist.+0.6577
BB Upper37.27 GBp
BB Middle34.95 GBp
BB Lower32.64 GBp
BB Width13.26%
ATR (14)2.664 GBp
Vol Ratio (20d)0.32x